ÂÜÀòÂÒÂ×

Yanis Tolstov has extensive work experience in the medical and scientific field. Yanis currently serves as the Chief Medical Officer at R-Biopharm AG since March 2020. Prior to this role, they worked at R-BIOPHARM as the Director of Marketing and Sales from October 2017 to March 2020, and as a Project Manager in the same department from October 2016 to October 2017.

Before joining R-BIOPHARM, Yanis worked at the University of Heidelberg as a Senior Scientist from October 2011 to September 2016. Prior to that, they held the position of Scientist at the University of Pittsburgh from January 2007 to September 2011.

Yanis also has experience as a Project Manager at The Biomedical Center from October 2003 to December 2006, and as a Research Assistant at the Research Institute of Physiology, St. Petersburg State University from December 1999 to September 2001.

Yanis Tolstov obtained a Bachelor of Science (BSc) degree in Biochemistry and Molecular Biology from St. Petersburg State University in St. Petersburg, Russia from 1993 to 1998. Yanis then pursued a Master of Science (MSc) degree in Biochemistry and Molecular Biology from the same institution from 1998 to 2000. Following this, Yanis attended Yale University from 2001 to 2006 and earned a Doctor of Philosophy (Ph.D.) degree in Virology. Additionally, they completed another Doctor of Philosophy (Ph.D.) degree in Virology from the Yale University School of Medicine, although the specific years of this program are not specified. Lastly, Yanis pursued a Master of Business Administration (MBA) degree in Strategy/Marketing from the University of Pittsburgh Katz Graduate School of Business from 2008 to 2011.